Note: Ingredients listed on restricted chemical lists
EC/CAS
101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
N/A
EC/CAS
9016-87-9
Name of the chemical
4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)
Concentration
N/A
General Information
Revision date
2014-01-06
Product name
FASTPATCH CT ISO
supplier name
Willamette Valley Company
Manufacturer Name
Willamette Valley Company
Emergency telephone
CALL INFOTRAC
Icons in SDS
Company Information
company name
Willamette Valley Company
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
Physical state Liquid. Emergency overview WARNING! CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION. MAY CAUSE ALLERGIC RESPIRATORY AND SKIN REACTION. Irritating to eyes, respiratory system and skin. May cause sensitization by inhalation and skin contact. Do not breathe vapor or mist. Do not get on skin or clothing. Avoid contact with eyes. Use only with adequate ventilation. Keep container tightly closed and sealed until ready for use. Wash thoroughly after handling.
Principle Routes of Exposure
Dermal contact. Eye contact. Inhalation.
Potential Acute Health Effects
Inhalation Irritating to respiratory system. May cause sensitization by inhalation. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion : No known significant effects or critical hazards. Skin Irritating to skin. May cause sensitization by skin contact. Eyes Irritating to eyes.
Potential chronic health
effects : Once sensitized, a severe allergic reaction may occur when subsequently exposed to very low levels. Carcinogenicity : No known significant effects or critical hazards. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : Contains material which may cause damage to the following organs: lungs, upper respiratory tract, eyes, nose/sinuses, testes, throat. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing wheezing and breathing difficulties asthma Ingestion : No specific data. Skin : Adverse symptoms may include the following: irritation redness Eyes : Adverse symptoms may include the following: pain or irritation watering redness Medical conditions Pre-existing respiratory and skin disorders may be aggravated by over-exposure to this aggravated by over- product. exposure
Additional information
Sensitization may develop as a result of a single large overexposure or from repeated overexposure at lower levels. Respiratory sensitization can result in a strong asthmatic response to future airborne exposures, even at levels well below the PEL/TLV. Symptoms may include coughing, wheezing, tightness in the chest and shortness of breath. The skin sensitization reaction may include rash, itching, hives, and swelling of the arms and legs. Sensitization can be either temporary or permanent. See toxicological information (Section 11) 3 .